The global crisis of drug-resistant tuberculosis and leadership of China and the BRICS : challenges and opportunities : summary of a joint workshop by the Institute of Medicine and the Institute of Microbiology, Chinese Academy of Sciences /
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, originally developed and introduced in the 1950 and 1960s. Since 2008, the Forum on Drug Discovery, Development, and Translation of the Institute of Med...
Clasificación: | Libro Electrónico |
---|---|
Autores principales: | , , |
Autores Corporativos: | , , |
Formato: | Electrónico Congresos, conferencias eBook |
Idioma: | Inglés |
Publicado: |
Washington, D.C. :
The National Academies Press,
[2014]
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- The challenges and opportunities for the BRICS countries to lead
- Catching up with the microbe
- Drug-resistant TB in China
- Experiences with MDR TB in other countries
- Drug-resistant tuberculosis in pediatric populations
- Global perspectives on transmission and infection control
- Rapid diagnostic technologies : status and limitations
- Addressing diagnosis and treatment across the spectrum of drug resistance
- Developing and strengthening the drug supply chain for drug-resistant TB
- Embracing a new vision for research
- What will be required to achive zero deaths from TB?
- Creating an evidence-based blueprint for action.